KLP Kapitalforvaltning AS Buys 293,700 Shares of Kenvue Inc. $KVUE

KLP Kapitalforvaltning AS increased its stake in shares of Kenvue Inc. (NYSE:KVUE) by 31.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,222,146 shares of the company’s stock after acquiring an additional 293,700 shares during the period. KLP Kapitalforvaltning AS’s holdings in Kenvue were worth $21,082,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. Cornerstone Planning Group LLC raised its holdings in Kenvue by 705.2% during the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock worth $25,000 after acquiring an additional 1,361 shares in the last quarter. NBT Bank N A NY raised its stake in Kenvue by 180.3% in the third quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after buying an additional 1,006 shares during the period. Salomon & Ludwin LLC bought a new stake in Kenvue in the third quarter valued at approximately $25,000. Golden State Wealth Management LLC raised its stake in Kenvue by 150.1% in the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock valued at $32,000 after buying an additional 1,190 shares during the period. Finally, Trust Co. of Vermont raised its stake in Kenvue by 50.9% in the third quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock valued at $39,000 after buying an additional 804 shares during the period. Institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

Several analysts have issued reports on KVUE shares. Argus upgraded Kenvue to a “hold” rating in a research note on Friday, March 6th. Citigroup dropped their price objective on Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 15th. Canaccord Genuity Group upped their price objective on Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a research note on Wednesday, February 18th. UBS Group dropped their price objective on Kenvue from $19.00 to $18.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 7th. Finally, Jefferies Financial Group lowered Kenvue from a “buy” rating to a “hold” rating and dropped their price objective for the company from $23.00 to $18.00 in a research note on Friday, January 30th. Three equities research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $19.33.

Kenvue Price Performance

Kenvue stock opened at $17.30 on Thursday. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $25.17. The stock’s 50 day moving average is $17.87 and its 200-day moving average is $17.13. The company has a current ratio of 0.96, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $33.21 billion, a price-to-earnings ratio of 22.47, a PEG ratio of 3.93 and a beta of 0.61.

Kenvue (NYSE:KVUE) last posted its earnings results on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.22 by $0.05. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The company had revenue of $3.78 billion for the quarter, compared to the consensus estimate of $3.68 billion. During the same quarter in the prior year, the business earned $0.26 earnings per share. The firm’s revenue for the quarter was up 3.2% on a year-over-year basis. Equities research analysts expect that Kenvue Inc. will post 1.1 EPS for the current year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were given a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a yield of 4.8%. Kenvue’s dividend payout ratio is currently 107.79%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.